LH - NYSE

Labcorp Holdings Inc.

LH·NYSE

$258.92

+0.47%

HealthcareMedical - Diagnostics & Research

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$21.23B

EPS10.5400

P/E Ratio24.57

Earnings Date07/23/2026

7.39%

Return on Invested Capital

42%

3Y+11.0%

5Y-24.0%

10Y+10.0%

10.17%

Return on Equity

10%

3Y-20.0%

5Y-38.0%

10Y-24.0%

4.77%

Return on Assets

17%

3Y-25.0%

5Y-39.0%

10Y-7.0%

Labcorp Holdings Inc. Management Team

LH · NYSE

Ms. Julia A. Wang

Chief Financial Officer & Executive Vice President

Compensation

$669,361

Born 1972(Age 54)

female

Ms. Amy B. Summy

EVice President, Chief Marketing Officer & Consumer Business Lead

Born 1966(Age 60)

female

Dr. Brian J. Caveney J.D., M.D., M.P.H.

EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer

Compensation

$1,290,969

Born 1974(Age 52)

Ms. Anita Z. Graham

Executive Vice President & Chief Human Resources Officer

Compensation

$1,576,023

Born 1971(Age 55)

female

Mr. Akinbolade Oyegunwa M.B.A., Ph.D.

Executive Vice President and Chief Information & Technology Officer

Born 1983(Age 43)

male

Ms. Sandra D. van der Vaart J.D.

Executive Vice President, Chief Legal Officer & Corporate Secretary

Born 1960(Age 66)

female

Mr. Mark S. Schroeder

Executive Vice President, President of Diagnostics Laboratories & Chief Operating Officer

Compensation

$1,455,940

Born 1961(Age 65)

male

Mr. Adam H. Schechter

President, Chief Executive Officer & Chairman

Compensation

$4,149,118

Born 1965(Age 61)

male

Mr. Peter J. Wilkinson

Senior Vice President & Chief Accounting Officer

Born 1971(Age 55)

male

Christin O'Donnell

Vice President of Investor Relations

INSIDER TRANSACTIONS

Labcorp Holdings Inc. Insider Positioning

LH · NYSE

During the last 12 months, insiders have sold $14.60M worth of LH shares, with no buying activity reported.

3 Months

Bought

0.00

Sold

8.4K

2.16M

Net Activity

-2.2M

-$2.16M

3-6 Months

Bought

0.00

Sold

17.0K

4.78M

Net Activity

-4.8M

-$4.78M

6-9 Months

Bought

0.00

Sold

12.8K

3.29M

Net Activity

-3.3M

-$3.29M

9-12 Months

Bought

0.00

Sold

16.1K

4.36M

Net Activity

-4.4M

-$4.36M

Top Buyers

No buying activity

Top Sellers

SAH

Schechter Adam H

Director, Officer: President & Ceo

31.3K shares•5 transactions

$8.45M

PRP

Parham Richelle P

Director

7.0K shares•1 transactions

$1.78M

AKB

Anderson Kerrii B

Director

4.5K shares•3 transactions

$1.24M

VDVSD

Van Der Vaart Sandra D

Officer: Evp, Corporate Affairs

4.5K shares•2 transactions

$1.22M

WPJ

Wilkinson Peter J

Officer: Svp, Chief Accounting Officer

2.4K shares•3 transactions

$647K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $14.60M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$2.16M

Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.

Insider Participation

High Selling

5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.

SEC PROXY FILINGS

SEC Filings

LH - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
DEF 14A DEF 14A 2026 N/A	April 10, 2026	April 10, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	April 04, 2025	May 15, 2025	2025	View Filing
DEF 14A DEF 14A 2024 N/A	April 04, 2024	May 14, 2024	2024	View Filing
DEF 14A DEF 14A N/A	March 30, 2023	March 30, 2023		View Filing
DEF 14A DEF 14A 2022 N/A	March 31, 2022	May 11, 2022	2022	View Filing
DEF 14A DEF 14A 2021 N/A	April 02, 2021	May 12, 2021	2021	View Filing
DEF 14A DEF 14A 2020 N/A	April 01, 2020	May 13, 2020	2020	View Filing
DEF 14A DEF 14A 2019 N/A	March 29, 2019	May 09, 2019	2019	View Filing
DEF 14A DEF 14A 2018 N/A	March 30, 2018	May 10, 2018	2018	View Filing
DEF 14A DEF 14A 2017 N/A	March 31, 2017	May 11, 2017	2017	View Filing

Showing 1 to 10 of 32 filings

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.